Expression of dendritic cell markers on bone marrow cells in a fraction enriched for the ability to prolong skin allograft survival in ALS-treated murine recipients.
Masli
S
S
Bouvé College of Pharmacy and Health Sciences, Northeastern University, Boston, Massachusetts 02115, USA.
De Fazio
S R
SR
Gozzo
J J
JJ
D000818:Animals; D000961:Antilymphocyte Serum / Q000627:therapeutic use*; D018122:B7-1 Antigen / Q000032:analysis; D015415:Biomarkers; D015704:CD4 Antigens / Q000032:analysis; D016827:CD8 Antigens / Q000032:analysis; D002469:Cell Separation; D002478:Cells, Cultured; D003713:Dendritic Cells / Q000166:cytology / Q000187:drug effects / Q000276:immunology*; D006085:Graft Survival / Q000276:immunology*; D016178:Granulocyte-Macrophage Colony-Stimulating Factor / Q000494:pharmacology; D018380:Hematopoietic Stem Cell Transplantation; D006412:Hematopoietic Stem Cells / Q000166:cytology / Q000187:drug effects / Q000276:immunology*; D000949:Histocompatibility Antigens Class II / Q000032:analysis / Q000096:biosynthesis*; D016130:Immunophenotyping; D007165:Immunosuppression Therapy / Q000379:methods; D015847:Interleukin-4 / Q000494:pharmacology; D051379:Mice; D008809:Mice, Inbred C3H; D016038:Skin Transplantation / Q000276:immunology*
D000961:Antilymphocyte Serum; D018122:B7-1 Antigen; D015415:Biomarkers; D015704:CD4 Antigens; D016827:CD8 Antigens; D000949:Histocompatibility Antigens Class II; D015847:Interleukin-4; D016178:Granulocyte-Macrophage Colony-Stimulating Factor